Wireless, variable inductance and resonant circuit-based vascular monitoring devices, systems, methodologies, and techniques, including specifically configured anchoring structures for same, are disclosed that can be used to assist healthcare professionals in predicting, preventing, and diagnosing various heart-related and other health conditions.

Self-righting articles, such as self-righting capsules for administration to a subject, are generally provided. In some embodiments, the self-righting article may be configured such that the article may orient itself relative to a surface (e.g., a surface of a tissue of a subject). The self-righting articles described herein may comprise one or more tissue engaging surfaces configured to engage (e.g., interface with, inject into, anchor) with a surface (e.g., a surface of a tissue of a subject). In some embodiments, the self-righting article may have a particular shape and/or distribution of density (or mass) which, for example, enables the self-righting behavior of the article. In certain embodiments, the self-righting article a tissue-interfacing components. In some embodiments, each tissue-interfacing component may comprise an electrically-conductive portion configured for electrical communication with tissue and an insulative portion configured to not be in electrical communication with tissue.

The capsule includes a tubular body and a front-end unit including an anchoring member for the anchoring of the capsule to a wall of a patient's organ. The front-end unit is mobile in relative axial rotation with respect to the tubular body, and a disengageable coupling member is adapted to allow this relative rotation when the tubular body receives an external rotational stress, the anchoring member then exerting a reaction torque higher than a predetermined threshold torque, and to prevent the relative rotation in the absence of external rotational stress applied to the tubular body. The coupling member may in particular include, between the front-end unit and the tubular body, a friction interface, with an elastically deformable element applying an axial compression between a bearing face of the tubular body and a support ring integral with the anchoring member.

A system and method are provided to deploy an implant assembly in a vessel. The implant assembly comprises a pressure sensor having a body, and first and second anchoring members coupled to the body of the pressure sensor. A delivery apparatus comprises a shaft having proximal and distal ends, the shaft including a main lumen and a secondary lumen, the main lumen extending along at least a portion of the shaft. The secondary lumen extends along at least a portion of the length of the shaft, the secondary lumen joined with first and second ports provided in a sidewall of the shaft. A tether wire is configured to be slidably positioned within the secondary lumen, the tether wire having a distal portion configured to secure the implant assembly against the sidewall.

A surgical system for intra-operative and post-operative measurement of motion and position of the musculoskeletal system. The surgical system comprises a surgical navigation system configured to support the installation of at least one prosthetic component. The surgical navigation system measures motion and position of the musculoskeletal system during surgery. Holes are drilled in a first bone and a second bone of the musculoskeletal system to retain tracking devices of the surgical navigation system. Leaving the holes in the first bone and the second bone after completing the surgery can introduce stress risers that could reduce bone integrity. The surgical system includes a first implantable device and a second implantable device each having anchors corresponding to the holes of the first bone and the second bone. The first implantable device and the second implantable device each has an IMU to measure motion and position post-operatively. The anchors are configured to reduce stress risers.

Systems and methods for closed-loop control of heart failure interventional therapies using closed-loop feedback from vascular implanted cardiac health status sensors are disclosed.

Self-righting articles, such as self-righting capsules for administration to a subject, are generally provided. In some embodiments, the self-righting article may be configured such that the article may orient itself relative to a surface (e.g., a surface of a tissue of a subject). The self-righting articles described herein may comprise one 5 or more tissue engaging surfaces configured to engage (e.g., interface with, inject into, anchor) with a surface (e.g., a surface of a tissue of a subject). In some embodiments, the self-righting article may have a particular shape and/or distribution of density (or mass) which, for example, enables the self-righting behavior of the article. In certain embodiments, the self-righting article a tissuel0 interfacing components. In some embodiments, each tissue-interfacing component may comprise an electrically-conductive portion configured for electrical communication with tissue and an insulative portion configured to not be in electrical communication with tissue.

An implantable intraocular physiological sensor for measuring intraocular pressure, glucose concentration in the aqueous humor, and other physiological characteristics. The implantable intraocular physiological sensor may be at least partially powered by a fuel cell, such as an electrochemical glucose fuel cell. The implantable intraocular physiological sensor may wirelessly transmit measurements to an external device. In addition, the implantable intraocular physiological sensor may incorporate aqueous drainage and/or drug delivery features.

A medical device is configured to sense an acceleration signal and determine at least one frequency metric from the acceleration signal that is correlated to a frequency of oscillations of the acceleration signal. The medial device is configured to determine that the at least one frequency metric meets atrial tachyarrhythmia criteria and detect an atrial tachyarrhythmia in response to at least the frequency metric meeting the atrial tachyarrhythmia criteria.

Disclosed herein are joint implants and methods for tracking joint implant performance. A method for monitoring a joint implant performance may include coupling a first implant to a first bone of a joint, the first implant including at least one magnetic marker. Coupling a second implant to a second bone of the joint, the second implant including at least one magnetic sensor to detect a position of the magnetic marker. Performing a first joint stress test to measure a baseline joint stability value, the baseline joint stability value being generated by the at least one magnetic sensor. Performing a second joint stress test to measure a second joint stability value, the second joint stability value being generated by the at least one magnetic sensor. Determining joint stability of the joint by comparing the baseline joint stability value to the second joint stability value.